X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (228) 228
Publication (53) 53
Book Review (46) 46
Conference Proceeding (12) 12
Book Chapter (10) 10
Book / eBook (6) 6
Patent (4) 4
Web Resource (3) 3
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (126) 126
humans (116) 116
oncology (97) 97
clinical neurology (66) 66
female (56) 56
male (52) 52
adult (51) 51
middle aged (46) 46
chemotherapy (45) 45
radiotherapy (39) 39
surgery (38) 38
aged (35) 35
brain neoplasms - pathology (30) 30
brain neoplasms - therapy (30) 30
radiation-therapy (30) 30
gliomas (29) 29
prognosis (29) 29
tumors (29) 29
brain neoplasms - secondary (27) 27
cancer (27) 27
treatment outcome (27) 27
brain neoplasms - drug therapy (25) 25
neurology (25) 25
brain metastases (24) 24
care and treatment (24) 24
medicine & public health (24) 24
glioblastoma (23) 23
phase-ii trial (23) 23
temozolomide (21) 21
brain tumors (20) 20
metastasis (20) 20
patients (20) 20
antineoplastic agents - therapeutic use (19) 19
retrospective studies (19) 19
brain neoplasms - mortality (18) 18
magnetic resonance imaging (18) 18
survival (18) 18
brain neoplasms - radiotherapy (17) 17
cell lung-cancer (17) 17
clinical trials (16) 16
highlights from the literature (16) 16
stereotactic radiosurgery (16) 16
adolescent (15) 15
combined modality therapy (15) 15
diagnosis (15) 15
neurosciences (15) 15
radiation therapy (15) 15
radiosurgery (15) 15
randomized-trial (15) 15
survival analysis (15) 15
aged, 80 and over (13) 13
bevacizumab (13) 13
brain (13) 13
brain cancer (13) 13
brain neoplasms - diagnosis (13) 13
brain neoplasms - surgery (13) 13
hematology, oncology and palliative medicine (13) 13
phase-ii (13) 13
quality of life (13) 13
radiation (13) 13
central-nervous-system (12) 12
follow-up studies (12) 12
glioma - drug therapy (12) 12
quality-of-life (12) 12
research (12) 12
surgical resection (12) 12
young adult (12) 12
disease-free survival (11) 11
glioma - therapy (11) 11
radiology, nuclear medicine & medical imaging (11) 11
survival rate (11) 11
dacarbazine - analogs & derivatives (10) 10
glioma (10) 10
glioma - pathology (10) 10
health aspects (10) 10
low-grade gliomas (10) 10
mutation (10) 10
prognostic-factors (10) 10
therapy (10) 10
toxicity (10) 10
brain neoplasms - genetics (9) 9
brain-tumors (9) 9
cerebral metastases (9) 9
child (9) 9
clinical trials as topic (9) 9
dacarbazine - therapeutic use (9) 9
gamma-knife radiosurgery (9) 9
medical prognosis (9) 9
neoplasm grading (9) 9
pathology (9) 9
prognostic factors (9) 9
radiosurgery - adverse effects (9) 9
seizures (9) 9
abstracts (8) 8
adjuvant temozolomide (8) 8
analysis (8) 8
brain - pathology (8) 8
brain neoplasms - complications (8) 8
brain neoplasms - epidemiology (8) 8
cancer therapies (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current opinion in neurology, ISSN 1350-7540, 12/2018, Volume 31, Issue 6, pp. 718 - 719
Journal Article
Neuro-Oncology, ISSN 1522-8517, 10/2017, Volume 19, Issue 10, pp. 1292 - 1293
Journal Article
2012, Handbook of clinical neurology, ISBN 9780444521385, Volume 3rd ser., v. 104-105
Web Resource
European Journal of Neurology, ISSN 1351-5101, 09/2010, Volume 17, Issue 9, pp. 1124 - 1133
Journal Article
Journal Article
Neurosurgery, ISSN 0148-396X, 08/2013, Volume 73, Issue 2, p. 255
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. e395 - e403
Journal Article
Journal Article
Neurosurgery, ISSN 0148-396X, 09/2012, Volume 71, Issue 3, p. 740
Journal Article
Neuro-Oncology, ISSN 1522-8517, 01/2018, Volume 20, Issue 1, pp. 6 - 7
Journal Article
02/2019, ISBN 9783319956831, 254
eBook
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Summary Background Chemotherapy with high-dose methotrexate is the conventional approach to treat primary CNS lymphomas, but superiority of polychemotherapy... 
Internal Medicine | DEFERRED RADIOTHERAPY | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | INTERNATIONAL WORKSHOP | RESPONSE CRITERIA | EUROPEAN ORGANIZATION | CONSOLIDATING RADIOTHERAPY | NON-HODGKINS-LYMPHOMA | INITIAL TREATMENT | CENTRAL-NERVOUS-SYSTEM | CEREBROSPINAL-FLUID | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
Neuro-Oncology, ISSN 1522-8517, 2017, Volume 19, Issue 2, pp. 143 - 144
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 2/2014, Volume 116, Issue 3, pp. 533 - 541
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 07/2017, Volume 44, Issue 7, pp. 1155 - 1164
Journal Article
Expert Review of Neurotherapeutics, ISSN 1473-7175, 01/2014, Volume 14, Issue 1, pp. 1 - 3
Trials on recurrent glioblastoma have shown that bevacizumab alone is able to increase response rate on MRI, median and 6-month progression-free survival... 
cilengitide | glioblastoma | EFFICACY | VEGF | RECURRENT GLIOBLASTOMA | bevacizumab | PHARMACOLOGY & PHARMACY | RADIOTHERAPY | cediranib | COMBINATION | CLINICAL NEUROLOGY | TEMOZOLOMIDE | Angiogenesis Inhibitors - therapeutic use | Clinical Trials as Topic | Brain Neoplasms - drug therapy | Glioblastoma - drug therapy | Humans
Journal Article